Treatment of Dilated Cardiomyopathy with Qilan Qiangxin Capsule Combined with Sakubatra and Valsartan: A Case Report

Authors

  • Tong Li First Clinical Medical College of Shaanxi University of Traditional Chinese Medicine
  • Cuiying Zhang Department of Cardiovascular Medicine, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine

DOI:

https://doi.org/10.30564/jams.v3i1.1305

Abstract

A case of dilated cardiomyopathy was reported, including the course of onset and long-term application of Qilan Qiangxin Capsule combined with a new anti-heart failure drug, Sakubatril Valsartan, in order to improve the symptoms of heart failure, increase the LVEF (left ventricular ejection fraction), and reduce the plasma NT-proBNP (N-terminal B-type natriuretic peptide) level. The effect of improving ventricular remodeling is obvious, and the quality of life of patients is improved

Keywords:

Dilated cardiomyopathy, Sakubatril valsartan, Qilan Qiangxin capsule

References

[1] Zhou Zheng, Wang Zongsheng, Dong Yao-rong. Observation on therapeutic effect of blood-nourishing and Blood-Activating Therapy on dilated cardiomyopathy with heart failure [J].Shandong Journal of Traditional Chinese Medicine, 2018,37(10): 811-813.

[2] Observation on the therapeutic effect of Zhang Jungyi, Wu Yue, Liu Haizhen, Qiqiangxin Capsule on elderly patients with chronic heart failure [J].Liaoning Journal of Traditional Chinese Medicine, 2017,44(05): 991-993.

[3] Liu Yanhua, Li Feng, Wang Jiaolong, Li Hongmao, Shakubaqutra and Valsartan in the treatment of chronic heart failure [J]. Journal of Changchun University of Traditional Chinese Medicine, 2019, 35 (03): 457-460.

[4] Clinical study of Wang Renping, Zhang Min, Wang Lei, Sun Shanshan, Lv Zhixin, Huang Ruixia, Xu Hongzun, Li Qinghua, Hou Xi. Myocardial Vitality Granules in the treatment of dilated cardiomyopathy with heart failure of Qi deficiency and blood stasis type [J].Hebei Traditional Chinese Medicine, 2012, 34 (04): 489-491+494.

[5] Zhang Mini, Ko Lanjun, Liu Chang, Sun Fei. Progress in the treatment of dilated cardiomyopathy with integrated traditional Chinese and Western medicine [J].Journal of Cardiovascular and Cerebrovascular Diseases of Integrated Traditional Chinese and Western Medicine, 2018,16(19): 2804-2808.

[6] Zhu Haimei, Longyun, Gu Dawei, Wang Min, Liu Jianhe, Jin Chaohui, Cheng Uofu. Cheng Uofu's Experience in the Treatment of Dilated Cardiomyopathy [J]. Chinese Medicine Report, 2017, 23 (06): 45-46.

[7] Application of Li Jinrong, Qilan Qiangxin Capsule and Digoxin in the Treatment of Chronic Systolic Heart Failure [J].Journal of Clinical Chinese Medicine, 2019, 31 (04): 782-784.

[8] Research progress on the mechanism of Zhao Qifei, Li Hongrong, Yin Yujie, Chang Liping, Jia Zhenhua. Qilu Qiangxin Capsule in treating chronic heart failure [J].Tianjin Traditional Chinese Medicine, 2019, 36 (04): 313-318.

[9] Effects of Lei Zhengyi, Wang Shuoren, Lu Weixing, Yu Weijie, Guo Weiqin, Liao Jiazhen, Qinhong, Zhao Yueru, Qin Lamei, Wang Qingchun. Astragalus membranaceus on cardiac function in patients with angina [J]. Chinese Journal of Integrated Traditional and Western Medicine, 1994 (04): 199-202+195.

[10] Sun Liwei, Li Xiangyan, Zhao Daqing. Study on the connotation of TCM and biology of Ginseng "Dabu Yuanqi"[J].World Science and Technology-Modernization of TCM, 2016,18(11): 1969-1974.

[11] Song Jianbin, Meng Tao. Clinical observation of TCM syndrome differentiation therapy combined with compound Danshen injection in the treatment of cerebral infarction [J]. Journal of Practical Cardiocerebral Pulmonary Vascular Disease, 2015, 23 (03): 129-130.

[12] The effect of Tao Ling, Du Tao, Miao Jinlong, Zhang Yujie Qiqiangxin Capsule on plasma NT-proBNP level in elderly patients with ischemic cardiomyopathy and heart failure [J].Western Chinese Medicine, 2015, 28 (08): 75-77.

[13] Inhibitory effects of pretreatment with Pei Zhiping, Niu Cultural Revolution, Chai Jingbo and Meng Jie-Huangqi on oxidative stress and inflammation after mesenteric ischemia-reperfusion injury in rats [J].Chinese Medicine Emergency, 2016, 25 (06): 967-970.

[14] Jiang Jianhua. Clinical Study of Qilu Qiangxinjiaoxiang on Chronic Heart Failure [J]. Journal of Traditional Chinese Medicine, 2013, 28 (09): 1370-1371.

[15] Zhang Yan, Liu Xiaolei, Wang Chen. Evaluation of the therapeutic effect of invigorating Qi and activating blood on chronic heart failure [J]. Chinese Journal of Traditional Chinese Medicine Information, 2011, 18 (11): 72-73.

[16] Luo Chuanjin, Chen Yuexuan, Chen Yi, Shi Jishuo, Zhang Lu, Gao Jiazhu, Zhou Xiaoqi, Huang Jin, Wu Hui, Li Rong. Relevance analysis of clinical medication for dilated cardiomyopathy [J]. New Chinese Medicine, 2019, 51 (08): 46-50.

[17] Bian Rutao, Wang Zhentao. Research progress of TCM in the treatment of dilated cardiomyopathy [J]. Journal of Cardiocerebrovascular Disease, Integrated Chinese and Western Medicine, 2019, 17 (12): 1826-1828.

[18] Chen Chunwang. The effect of Sakubatra and Valsartan on chronic heart failure [J]. Electronic Journal of Cardiovascular Disease of Integrated Traditional Chinese and Western Medicine, 2019, 7 (22): 40-41.

[19] Zhao Yuehua, Wang Zhanqi, Shi Xiangxin, Qi Jinlei, Shakuba Trivalsartan (LCZ696) in the treatment of heart failure [J].Journal of Clinical Cardiovascular Diseases, 2019,35 (06): 491-494.

[20] Zhang Xiaohong, Xue Jingyi, Li Jianqiang, Li Weimin. Clinical application of valsartan in the treatment of heart failure [J]. Journal of Clinical Cardiovascular Disease, 2018, 34 (12): 1215-1218.

[21] Effect of Zhang Jiangwu, Xie Zhihui, Wu Fanghui, Hou Dongzi, Sakubattral and Valsartan Sodium Tablets (Noxinto) on the Curative Effect and BNP Level in Patients with Chronic Heart Failure [J].Jilin Medical Science, 2019, 40 (07): 1430-1433.

[22] Date of submission: 2019-08-31.

Downloads

Issue

Vol. 3 , Iss. 1 (January 2020)

Article Type

Review Article

License

Copyright and Licensing

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

Journal of Advances in Medicine Science publishes accepted manuscripts under Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). Authors who submit their papers for publication by Journal of Advances in Medicine Science agree to have the CC BY-NC 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for non-commercial use. As long as you follow the license terms and original source is properly cited, anyone may copy, redistribute the material in any medium or format, remix, transform, and build upon the material.

License Policy for Reuse of Third-Party Materials

If a manuscript submitted to the journal contains the materials which are held in copyright by a third-party, authors are responsible for obtaining permissions from the copyright holder to reuse or republish any previously published figures, illustrations, charts, tables, photographs, and text excerpts, etc. When submitting a manuscript, official written proof of permission must be provided and clearly stated in the cover letter.
The editorial office of the journal has the right to reject/retract articles that reuse third-party materials without permission.

Journal Policies on Data Sharing

We encourage authors to share articles published in our journal to other data platforms, but only if it is noted that it has been published in this journal.